Famous Among Top Surgeons in the 90s
Chapter 996: The Meaning of 996

Chapter 996: The Meaning of 996

Professor Hao, wearing glasses and dressed elegantly in a suit and tie, had a friendly and approachable appearance.

Two assistants brought over a computer to help project the PowerPoint presentation for the lecture.

"Colleagues, today I bring you a special lecture on some of the latest research developments in PTCD intrabiliary radiotherapy. This technology, introduced from abroad, has been rapidly developing in our country for over ten years. It is not yet widely used in our country but is quite advanced. Currently, the technology we use mainly involves iridium-192 wires entering the bile duct for brachytherapy. Regarding the placement and the distance from the tumor, these aspects require more detailed studies. Our hospital has been utilizing this technology for over eight years, and I am here to share some insights and experiences with you."

Despite being a professor, he was very modest when discussing academic issues, speaking steadily with the scholarly air.

The audience below was totally silent, quietly absorbing the learning.

"Cholangiocarcinoma is not very sensitive to chemotherapy. This technology was initially not applied to cholangiocarcinoma. However, after its clinical application, we have seen many encouraging findings. For instance, for tumors smaller than 1.5 cm, internal radiation alone can be used, which can significantly extend survival. For tumors larger than 1.5 cm, it is best to add external beam radiation. This definitely provides much better results than just external radiation alone, and can relatively extend the patients’ survival."

It seems that as he spoke, Professor Hao found the conference room a bit stuffy, so he adjusted the atmosphere by saying to the audience below, "If you have any thoughts or suggestions, feel free to raise your hand and ask questions or make comments at any time."

Hearing this, someone raised their hand.

An assistant immediately handed the microphone to this person.

"Doctor Hao, is this technology only used for palliative treatment? Our hospital has considered applying it pre- and post-surgery. We are curious if your hospital has attempted this and researched whether reducing tumor size pre-surgery and removing residual tumor tissues post-surgery is significant? We have reviewed related literature where peers have conducted similar studies but apparently, the cases are few. Could Professor Hao address these inquiries?"

The doctor who asked the question raised a series of practical issues, clearly showing he was a frontline physician.

Professor Hao smiled, asked him to sit down, and explained: "Regarding your questions, especially the last one about why it’s less commonly used pre- and post-surgery. Mainly because, aside from shrinking tumors pre-surgery and removing residual tumor tissues post-surgery, we have other technologies. As I mentioned earlier, cholangiocarcinoma is relatively insensitive to radiation therapy. We can use advanced chemotherapy drugs to shrink tumors and remove residual tissues. This technology has certain advantages in palliative care because it can locally eliminate tumors. In the future, with more advanced drugs, we might not need stents to maintain drainage."

After the expert finished speaking, the primary care doctors were inspired and stood up to express their gratitude.

The lecture continued. Issues about dosage, radiation distance, and various research charts appeared on the PowerPoint. The audience watched, some taking notes with pens. Although this technique is not a surgical procedure, the adjunct therapy is crucial for surgery. In some cases where patients cannot undergo surgery, doctors indeed need to find alternative methods.